Overview
Dr. Peter Mogayzel is the Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pediatric pulmonary medicine and the treatment of cystic fibrosis. He has served as the director of the Johns Hopkins Cystic Fibrosis Center since 2002. Dr. Mogayzel attended Brown University and received his M.D. and Ph.D. degrees from Boston University and an M.B.A. from Johns Hopkins University. He completed his pediatric residency at the University of Washington, and finished pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty. His research interests include the regulatory properties of the CFTR gene, mucociliary clearance and development of new therapeutics for cystic fibrosis. Dr. Mogayzel has provided care for children with cystic fibrosis and has been active in the CF community since his arrival at Johns Hopkins. He served as Chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee and the Therapeutic Development Network Protocol Review Committee both of the Cystic Fibrosis Foundation. He is also a past Chairman of the Cystic Fibrosis Foundation Center Committee which accredits cystic fibrosis care centers in the US. He is currently a member of the Board of Directors of the Cystic Fibrosis Foundation.
Dr. Mogayzel is rated as an Experienced provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Pseudomonas Stutzeri Infections.
His clinical research consists of co-authoring 51 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Pseudomonas Stutzeri Infections.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
Locations
200 North Wolfe Street, Rubenstein BLDG Lower Level, Rubenstein BLDG Lower Level, Baltimore, MD 21287
1708 West Rogers Avenue, Baltimore, MD 21209
820 Bestgate Road, Suite 2D, Annapolis, MD 21401
Additional Areas of Focus
Dr. Mogayzel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Rubenstein Child Health Building
Dr. J. Michael Collaco is a professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical specialty is pediatric pulmonary medicine, including chronic lung disease of premature infants, lung disease in medically complex patients including ventilators and tracheostomies, hereditary hemorrhagic telangiectasia, aerodigestive disorders, and general pediatric pulmonary conditions. He sees patients inpatient and outpatient at Johns Hopkins (East Baltimore campus), inpatient and outpatient at Mount Washington Pediatric Hospital, and inpatient at Kennedy Krieger Institute. Dr. Collaco attended Yale University for undergraduate studies and received his M.D. and M.S. (Anatomy) from Case Western University School of Medicine in Cleveland, Ohio. He completed his pediatric residency, pediatric pulmonary fellowship, M.B.A., M.P.H., and Ph.D. (Clinical Epidemiology) at the Johns Hopkins University. Dr. Collaco joined the Johns Hopkins faculty in 2008. His primary research interest is in the epidemiology of pediatric respiratory diseases, with a focus on environmental risk factors for cystic fibrosis and bronchopulmonary dysplasia as well as a special interest in the effects of secondhand smoke and electronic cigarette emissions. He has published over 140 peer-reviewed articles. Dr. Collaco is a member of the Cystic Fibrosis Research Development Center and the Hereditary Hemorrhagic Telangiectasia Center of Excellence. He has been recognized by Johns Hopkins with the John C. Hume Scholarship, the Francis F. Schwentker Research Award, and the Robert Dyar Award. Dr. Collaco is a fellow of the American Academy of Pediatrics. Dr. Collaco is rated as a Distinguished provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Bronchopulmonary Dysplasia, Cystic Fibrosis, Pulmonary Hypertension, Pseudomonas Stutzeri Infections, and Gastrostomy.
Anastassios Koumbourlis is a Pediatric Pulmonologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Koumbourlis is rated as an Advanced provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Cystic Fibrosis, Asthma, Tracheoesophageal Fistula, and Ciliary Dyskinesia-Bronchiectasis.
Hollis Chaney is a Pediatric Pulmonologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Chaney is rated as an Advanced provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. Her top areas of expertise are Cystic Fibrosis, Asthma, Asthma in Children, and Secondary Immunodeficiency (SID). Dr. Chaney is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cystic FibrosisDr. Mogayzel isDistinguished. Learn about Cystic Fibrosis.
- Advanced
- Newborn JaundiceDr. Mogayzel isAdvanced. Learn about Newborn Jaundice.
- Secondary Immunodeficiency (SID)Dr. Mogayzel isAdvanced. Learn about Secondary Immunodeficiency (SID).
- Experienced
- Ciliary Dyskinesia-BronchiectasisDr. Mogayzel isExperienced. Learn about Ciliary Dyskinesia-Bronchiectasis.
- Congenital Unilateral Pulmonary HypoplasiaDr. Mogayzel isExperienced. Learn about Congenital Unilateral Pulmonary Hypoplasia.
- Exocrine Pancreatic InsufficiencyDr. Mogayzel isExperienced. Learn about Exocrine Pancreatic Insufficiency.
- HerniaDr. Mogayzel isExperienced. Learn about Hernia.
- JaundiceDr. Mogayzel isExperienced. Learn about Jaundice.
- Primary Ciliary Dyskinesia (PCD)Dr. Mogayzel isExperienced. Learn about Primary Ciliary Dyskinesia (PCD).